Raymond James initiates Odyssey Therapeutics coverage, sets $42 target
Raymond James started coverage of Odyssey Therapeutics with an Outperform rating and a $42 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.